|
[1]Hui JM, Sud A, Farrell GC, et al.Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression[J].Gastroenterology, 2003, 125 (6) :1695-1704.
|
|
[2]Moucari R, Asselah T, Cazals-Hatem D, et al.Insulin resistance in chronic hepatitis C:association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis[J].Gastroenterology, 2008, 134 (2) :416-423.
|
|
[3]Leandro G, Mangia A, Hui J, et al.Relationship between J Clini Hepatol, May 2011, Vol.27, No.5steatosis, inflammation, and fibrosis in chronic hepatitis C:a meta-analysis of individual patient data[J].Gastroenterology, 2006, 130 (6) :1636-1642.
|
|
[4]Kawaguchi Y, Mizuta T, Oza N, et al.Eradication of hepatitis C virus by interferon improves whole-body insulin resistance and hyperinsulinaemia in patients with chronic hepatitis C[J].Liver Int, 2009, 29 (6) :871-877.
|
|
[5]Khattab M, Emad M, Abdelaleem A, et al.Pioglitazone improves virological response to peginterferon alpha-2b/ribavirin combination therapy in hepatitis C genotype 4 patients with insulin resistance[J].2010, Liver Int, 30 (3) :447-454.
|
|
[6]Miyaaki H, Ichikawa T, Nakao K, et al.Predictive value of the phosphorylation of signal transducers and activators of transcription in the outcome of interferon therapy for chronic hepatitis C[J].Intervirology, 2008, 51 (6) :394-399.
|
|
[7]Pazienza V, Clement S, Pugnale P, et al.The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype-specific mechanisms[J].Hepatology, 2007, 45 (5) :1164-1171.
|
|
[8]Miyamoto H, Moriishi K, Moriya K, et al.Involvement of the PA28gamma-dependent pathway in insulin resistance induced by hepatitis C virus core protein[J].Virol, 2007, 81 (4) :1727-1735.
|
|
[9]Moriishi K, Shoji I, Mori Y, et al.Involvement of PA-28gamma in the propagation of hepatitis C virus[J].Hepatology, 2010, 52 (2) :411-420.
|
|
[10]Bernsmeier C, Duong FH, Christen V, et al.Virus-induced over-expression of protein phosphatase 2A inhibits insulin signalling in chronic hepatitis C[J].Hepatol, 2008, 49 (3) :429-440.
|
|
[11]Qiu Y, Ting Mao, Zhang Y, et al.A crucial role for RACK1 in the regulation of glucose-stimulated IRE1alpha activation in pancreatic beta cells[J].Sci Signal, 2010, 3 (106) :ra7.
|
|
[12]PersicoM, Svelto M, Andolfo I, et al.SOCS3 and IRS-1 gene expression differs between genotype 1 and genotype 2 hepatitis C virus-infected HepG2 cells[J].Clin Chem Lab Med, 2009, 47 (10) :1217-1225.
|
|
[13]Miyaaki H, Ichikawa T, Nakao K, et al.Predictive value of suppressor of cytokine signal 3 (SOCS3) in the outcome of interferon therapy in chronic hepatitis C[J].Hepatol Res, 2009, 39 (9) :850-855.
|
|
[14]Bensinger SJ, Tontonoz P.Integration of metabolism and inflammation by lipid-activated nuclear receptors[J].Nature, 2008, 454 (7203) :470-477.
|
|
[15]Kim K, Ha E, Park JY, et al.Hepatitis C virus NS5A protein increases hepatic lipid accumulation via induction of activation and expression of PPARgamma[J].FEBS Let, 2009, 583 (17) :2720-2726.
|
|
[16]Mankouri J, Tedbury PR, Gretton S, et al.Enhanced hepatitis C virus genome replication and lipid accumulation mediated by inhibition of AMP-activated protein kinase[J].Proc Natl Acad Sci U S A, 2010, 107 (25) :11549-11554.
|
|
[17]Vidali M, Tripodi MF, Ivaldi A, et al.Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C[J].J Hepatol, 2008, 48 (3) :399-406.
|
|
[18]Evans J, Goldfine I, Maddux B, et al.Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?[J].Diabetes, 2003, 52 (1) :1-8.
|
|
[19]Majano PL, Medina J, Zubía I, et al.N-Acetyl-cysteine modulates inducible nitric oxide synthase gene expression in human hepatocytes[J].J Hepatol, 2004, 40 (4) :632-637.
|
|
[20]Guo XQ, Wang YJ, Chang YZ, et al.The role of hepcidin on HCV-induced liver damage[J].Zhonghua GanZangBing ZaZhi, 2010, 18 (4) :318-320.
|
|
[21]Takeo M, Kobayashi Y, Fujita N, et al.Upregulation of transferrin receptor 2 and ferroportin 1 mRNA in the liver of patients with chronic hepatitis C[J].Gastroenterol Hepatol, 2005, 20 (4) :562-569.
|
|
[22]Arkan MC, Hevener AL, Greten FR, et al.IKK-beta links inflammation to obesity-induced insulin resistance[J].Nat Med, 2005, 11 (2) :191-198.
|
|
[23]Aksoz K, Unsal B, Kirci A, et al.The relationship between chronic HCV infection and the level of plasma adiponectin[J].Turk J Gastroenterol, 2008, 19 (4) :254-257.
|
DownLoad: